Solid pharmaceutical dosage form comprising a ritonavir and lopinavir solid dispersion

A solid pharmaceutical dosage form providing improved oral bioavailability is disclosed for inhibitors of HIV protease. In particular, the dosage form comprises a solid dispersion of at least one HIV protease inhibitor in at least one pharmaceutically acceptable water-soluble polymer and at least on...

Full description

Saved in:
Bibliographic Details
Main Authors GHOSH SOUMOJEET, LIEPOLD BERND, BREITENBACH JORG, ROSENBERG JORG, BERNDL GUNTHER, REINHOLD ULRICH, ALANI LAMAN
Format Patent
LanguageEnglish
Slovenian
Published 29.03.2013
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:A solid pharmaceutical dosage form providing improved oral bioavailability is disclosed for inhibitors of HIV protease. In particular, the dosage form comprises a solid dispersion of at least one HIV protease inhibitor in at least one pharmaceutically acceptable water-soluble polymer and at least one pharmaceutically acceptable surfactant.
Bibliography:Application Number: SI20040031996T